Recent Applications of Quantum Dots in Pharmaceutical Analysis

Nanotechnology has emerged as one of the most potential areas for pharmaceutical analysis. The need for nanomaterials in pharmaceutical analysis is comprehended in terms of economic challenges, health and safety concerns. Quantum dots (QDs)or colloidal semiconductor nanocrystals are new groups of fluorescent nanoparticles that bind nanotechnology to drug analysis. Because of their special physicochemical characteristics and small size, QDs are thought to be promising candidates for the electrical and luminescent probes development. They were originally developed as luminescent biological labels, but are now discovering new analytical chemistry applications, where their photo-luminescent properties are used in pharmaceutical, clinical analysis, food quality control and environmental monitoring. In this review, we discuss QDs regarding properties and advantages, advances in methods of synthesis and their recent applications in drug analysis in the recent last years.

Dopamine-Coated Carbon Nanodots: A Supramolecular Approach to Polydopamine Composite

The development of biocompatible composites constituted by polydopamine and fluorescent carbon dots represents a promising way of exploiting the extraordinary adhesive properties of polydopamine for multi-purpose technologies. Here, a supramolecular complex is realized by the assembly of dopamine on the carbon dots surface, and the optical and structural properties are investigated by means of different spectroscopic techniques, from time-resolved fluorescence to Raman and NMR spectroscopies. The results suggest that the catechol unit of dopamine plays the main role in the formation of the supramolecular complex, in which carbon nanodot fluorescence emission is quenched by a photoinduced electron transfer process. The interaction with the nanodots' basic surface sites promotes the oxidation of dopamine and drives to its oligomerization/polymerization on the nanodot surface.

A core-shell structure ratiometric fluorescent probe based on carbon dots and Tb3+ for the detection of anthrax biomarker

A novel core-shell structure ratiometric fluorescent probe was developed, which can selectively and sensitively detect 2,6-dipicolinic acid (DPA) as an anthrax biomarker. Carbon dots (CDs) was embedded into SiO₂ nanoparticles, which was acted as an internal reference signal. Tb³⁺ with green emission was connected to the carboxyl functionalized SiO₂, which was acted as a responsive signal. With the addition of DPA, the emission of CDs at 340 nm was unchanged, while the fluorescence of Tb³⁺ at 544 nm was enhanced by the antenna effect. In the concentration range of 0.1-2 μM, the fluorescence intensity ratio of I₅₄₄/I₃₄₀ showed a good linear relationship with the concentration of DPA, and the limit of detection (LOD) was 10.2 nM. In addition, the dual-emission probe showed an obvious fluorescence color change from colourless to green with increasing DPA under UV light, which enabled visual detection.

High quantum yield carbon dots and nitrogen-doped carbon dots as fluorescent probes for spectroscopic dopamine detection in human serum

Recent advances in fluorescent carbon dots have shown great potential for the sensing of biological molecules. In this study, one-step hydrothermally synthesised carbon dots (CD) and nitrogen doped carbon dots (NCD) with high quantum yields of 54.29% and 89.82%, respectively, were investigated and demonstrated to be a reliable, cost-effective, and naked-eye fluorescent probe for the detection of dopamine, a neurotransmitter, in human serum fluids. The current study is well supported by a comprehensive synthesis approach and has been described utilizing a variety of microscopic and spectroscopic techniques. The discovered approach is time and pH dependent, and it provides a robust platform for specifically detecting aberrant dopamine levels using a fluorescence quenching mechanism. Dopamine detection limits for CD were calculated to be 5.54 μM for CD and 5.12 μM for NCD, respectively. The fluorescence quenching shows a linear continuous trend with a range within 3.3-500 μM and 3.3-400 μM of dopamine concentration for CD and NCD respectively. To further verify the sensitivity of CD and NCD as fluorescent probes, interference studies in the presence of different biological components were also studied and validated. This work shows that carbon-based nanomaterials and their doped nanostructures, due to their high fluorescence, have significant potential as fluorescent probes in neurological disease diagnosis as they display high selectivity, sensitivity and fast responses in the real time spectroscopic detection of dopamine in human fluid samples.